Cargando…
Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers
Blood cancer, or leukemia, has a negative impact on the blood and/or bone marrow of children and adults. Acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) are two sub-types of acute leukemia. The Internet of Medical Things (IoMT) and artificial intelligence have allowed for the devel...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949784/ https://www.ncbi.nlm.nih.gov/pubmed/35336523 http://dx.doi.org/10.3390/s22062348 |
_version_ | 1784674985499951104 |
---|---|
author | Karar, Mohamed Esmail Alotaibi, Bandar Alotaibi, Munif |
author_facet | Karar, Mohamed Esmail Alotaibi, Bandar Alotaibi, Munif |
author_sort | Karar, Mohamed Esmail |
collection | PubMed |
description | Blood cancer, or leukemia, has a negative impact on the blood and/or bone marrow of children and adults. Acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) are two sub-types of acute leukemia. The Internet of Medical Things (IoMT) and artificial intelligence have allowed for the development of advanced technologies to assist in recently introduced medical procedures. Hence, in this paper, we propose a new intelligent IoMT framework for the automated classification of acute leukemias using microscopic blood images. The workflow of our proposed framework includes three main stages, as follows. First, blood samples are collected by wireless digital microscopy and sent to a cloud server. Second, the cloud server carries out automatic identification of the blood conditions—either leukemias or healthy—utilizing our developed generative adversarial network (GAN) classifier. Finally, the classification results are sent to a hematologist for medical approval. The developed GAN classifier was successfully evaluated on two public data sets: ALL-IDB and ASH image bank. It achieved the best accuracy scores of 98.67% for binary classification (ALL or healthy) and 95.5% for multi-class classification (ALL, AML, and normal blood cells), when compared with existing state-of-the-art methods. The results of this study demonstrate the feasibility of our proposed IoMT framework for automated diagnosis of acute leukemia tests. Clinical realization of this blood diagnosis system is our future work. |
format | Online Article Text |
id | pubmed-8949784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89497842022-03-26 Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers Karar, Mohamed Esmail Alotaibi, Bandar Alotaibi, Munif Sensors (Basel) Article Blood cancer, or leukemia, has a negative impact on the blood and/or bone marrow of children and adults. Acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) are two sub-types of acute leukemia. The Internet of Medical Things (IoMT) and artificial intelligence have allowed for the development of advanced technologies to assist in recently introduced medical procedures. Hence, in this paper, we propose a new intelligent IoMT framework for the automated classification of acute leukemias using microscopic blood images. The workflow of our proposed framework includes three main stages, as follows. First, blood samples are collected by wireless digital microscopy and sent to a cloud server. Second, the cloud server carries out automatic identification of the blood conditions—either leukemias or healthy—utilizing our developed generative adversarial network (GAN) classifier. Finally, the classification results are sent to a hematologist for medical approval. The developed GAN classifier was successfully evaluated on two public data sets: ALL-IDB and ASH image bank. It achieved the best accuracy scores of 98.67% for binary classification (ALL or healthy) and 95.5% for multi-class classification (ALL, AML, and normal blood cells), when compared with existing state-of-the-art methods. The results of this study demonstrate the feasibility of our proposed IoMT framework for automated diagnosis of acute leukemia tests. Clinical realization of this blood diagnosis system is our future work. MDPI 2022-03-18 /pmc/articles/PMC8949784/ /pubmed/35336523 http://dx.doi.org/10.3390/s22062348 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karar, Mohamed Esmail Alotaibi, Bandar Alotaibi, Munif Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers |
title | Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers |
title_full | Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers |
title_fullStr | Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers |
title_full_unstemmed | Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers |
title_short | Intelligent Medical IoT-Enabled Automated Microscopic Image Diagnosis of Acute Blood Cancers |
title_sort | intelligent medical iot-enabled automated microscopic image diagnosis of acute blood cancers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949784/ https://www.ncbi.nlm.nih.gov/pubmed/35336523 http://dx.doi.org/10.3390/s22062348 |
work_keys_str_mv | AT kararmohamedesmail intelligentmedicaliotenabledautomatedmicroscopicimagediagnosisofacutebloodcancers AT alotaibibandar intelligentmedicaliotenabledautomatedmicroscopicimagediagnosisofacutebloodcancers AT alotaibimunif intelligentmedicaliotenabledautomatedmicroscopicimagediagnosisofacutebloodcancers |